1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Recurrent Solid Tumor: new trials by email Literature Review of Recurrent Solid Tumor trials Research Report on Recurrent Solid Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer NT219, NT219 and ERBITUX® - Dose Escalation, NT219 and ERBITUX® - Expansion - Solid Tumor, Adult, Squamous Cell Carcinoma of Head and Neck | Phase 1 / Phase 2 | Completed | TyrNovo Ltd. | 52 | 2020-09-03 | 2024-09-19 |
Head and Neck Neoplasms (1) · Neoplasm Metastasis (1) · Squamous Cell Carcinoma of Head and Neck (1)
Carcinoma (1) · Carcinoma, Squamous Cell (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
TyrNovo Ltd. (1)
Israel (1) · United States (1)